Jonathan Jones - curasan AG Insider

CUR -- Germany Stock  

EUR 1.02  0.035  3.32%

Mr. Jonathan Lloyd Jones was appointed as Chief Financial Officer of Neuralstem Inc. effective May 18 2015. Mr. Lloyd Jones has more than 25 years of corporate finance and business development experience. Mr. Lloyd Jones is a Chartered Accountant and holds a Masters of Business Administration from Wharton School of the University of Pennsylvania and a BSc from the University of Bradford
Age: 53  CFO Since 2015      
49 6027 40 900 51
Lloyd Jones has a background in corporate finance, particularly in licensing and partnering initiatives and in instituting financial infrastructure. From January 2013 until October 2014, he served as Chief Financial Officer of Columbia Laboratories . Prior to that, from 2011 to 2012, Mr. Lloyd Jones served as Chief Financial Officer and Vice President of Corporationrationrationrate Development at TetraLogic Pharmaceuticals, a venturebacked pharmaceutical company. Additionally from 2006 to 2010, Mr. Lloyd Jones served as Vice President, Finance, at TransMolecular, a privatelyheld clinical stage biotech company.

Management Efficiency

The company has return on total asset (ROA) of (13.09) % which means that it has lost $13.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (42.32) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 265 K in total debt with debt to equity ratio (D/E) of 2.6 implying the company greatly relies on financing operations through barroing. curasan AG has Current Ratio of 2.1 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

curasan AG develops, produces, and markets biomaterials and medical devices for bone and tissue regeneration worldwide. The company was founded in 1988 and is based in Kleinostheim, Germany. curasan AG operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange. It employs 30 people.curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Lindigstrasse 4 and employs 30 people.

curasan AG Leadership Team

William Oldaker, Independent Director
David Castaneda, IR Contact
Stanley Westreich, Independent Director
Karl Johe, Chairman of the Board, Chief Scientific Officer
Scott Ogilvie, Independent Director
Catherine Sohn, Director
Richard Garr, President CEO, General Counsel, Director
Richard Daly, President CEO
Sandford Smith, Director
Jonathan Jones, CFO

Stock Performance Indicators

Did you try this?

Run Idea Breakdown Now


Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Idea Breakdown

curasan AG Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for curasan AG and Fielmann AG. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.